Stocks and Investing Stocks and Investing
Wed, July 26, 2023
Tue, July 25, 2023

Serge Belanger Upgraded (VRCA) to Strong Buy and Held Target at $10 on, Jul 25th, 2023


Published on 2024-10-28 05:06:40 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Upgraded "Verrica Pharmaceuticals Inc." (VRCA) to Strong Buy and Held Target at $10 on, Jul 25th, 2023.

Serge has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Monday, July 17th, 2023

Contributing Sources